Trials / Completed
CompletedNCT06036251
COVID-19 Pandemic Induced Stress and Symptoms
COVID-19 Pandemic Induced Stress and Symptoms - Follow-up Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 415 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The previous survey of oncology patients at University of California, San Francisco in 2020-2021 found an alarmingly high symptom burden and high levels of stress and loneliness among respondents. This is a follow-up study with the same sample of oncology patients and survivors who participated in the previous study
Detailed description
OBJECTIVES: 1. Evaluate for associations among general and disease-specific measures of stress and measures of social isolation and loneliness. 2. Evaluate for associations between general and disease-specific stress and common symptoms associated with cancer and its treatments. 3. Evaluate for associations between social isolation and loneliness and common symptoms associated with cancer and its treatments. 4. Evaluate for associations between social isolation and loneliness and health behaviors and quality of life (QOL) as compared to our last survey. as a baseline. 5. Evaluate for changes in stress, social isolation, loneliness and symptom burden between the two time points. OUTLINE: Patients will be asked to complete self-report questionnaires online. Questionnaires will take approximately 60 minutes to complete. and directed to take rest periods at 20 minute intervals. Participants will be given two weeks to complete the instruments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires | Self-reported quality of life (QOL) measures completed online |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-04-30
- Completion
- 2023-04-30
- First posted
- 2023-09-13
- Last updated
- 2023-09-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06036251. Inclusion in this directory is not an endorsement.